Inventor
REICHARD GREGORY A
US22 patents
⚠️ This page may combine multiple inventors who share the name “REICHARD GREGORY A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
15 patentsUS7049320B2May 23, 2006
NK1 antagonists
SCHERING CORP54 citations96
US5696267ADec 9, 1997
Substituted oximes, hydrazones and olefins as neurokinin antagonists
SCHERING CORP70 citations95
US6635630B2Oct 21, 2003
Selective neurokinin antagonists
SCHERING CORP41 citations92
US6436928B1Aug 20, 2002
Selective neurokinin antagonists
SCHERING CORP17 citations92
US5789422AAug 4, 1998
Substituted arylalkylamines as neurokinin antagonists
SCHERING CORP51 citations92
US7122677B2Oct 17, 2006
NK1 antagonists
SCHERING CORP26 citations91
US5840725ANov 24, 1998
Substituted oximes, hydrazones and olefins as neurokinin antagonists
SCHERING CORP26 citations91
US6204265B1Mar 20, 2001
Substituted oximes and hydrazones as neurokinin antagonists
SCHERING CORP31 citations90
US5945428AAug 31, 1999
Substituted oximes, hydrazones and olefins as neurokinin antagonists
SCHERING CORP15 citations74
US6878732B2Apr 12, 2005
NK1 antagonists
SCHERING CORP10 citations73
US6063926AMay 16, 2000
Substituted oximes as neurokinin antagonists
SCHERING CORP14 citations73
US6534502B2Mar 18, 2003
Substituted oximes and hydrazones as neurokinin antagonists
SCHERING CORP2 citations60
US6403582B2Jun 11, 2002
Substituted oximes and hydrazones as neurokinin antagonists
SCHERING CORP2 citations60
US7498438B2Mar 3, 2009
Fused ring NK1 antagonists
SCHERING CORP0 citations52
US6569872B1May 27, 2003
Use of neurokinin receptor antagonists to treat androgen-dependent diseases
SCHERING CORP1 citations39